Clinical Trial Update: A Dose Escalation Study of Adavosertib (MK-1775) in Combination With Either Gemcitabine, Cisplatin, or Carboplatin in Adults With Advanced Solid Tumors (MK-1775-001) [Phase 1]

View source ↗

Summary

Phase 1 dose-escalation trial of adavosertib (MK-1775) in combination with gemcitabine, cisplatin, or carboplatin in adults with advanced solid tumors; trial co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• Adavosertib (adavosertib)
• CARBOPLATIN (Carboplatin)
• CISPLATIN (cisplatin)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Solid Tumors | Phase 1 | Status: COMPLETED | Results posted: 2019-04-05